Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) shares were up 5.5% during mid-day trading on Wednesday . The company traded as high as $5.36 and last traded at $5.35. Approximately 165,486 shares were traded during trading, a decline of 52% from the average daily volume of 341,812 shares. The stock had previously closed at $5.07.
Wall Street Analysts Forecast Growth
Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.
View Our Latest Research Report on BNGO
Bionano Genomics Trading Up 1.3 %
Institutional Trading of Bionano Genomics
A number of institutional investors have recently made changes to their positions in BNGO. Carret Asset Management LLC increased its stake in Bionano Genomics by 89.0% in the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after buying an additional 40,055 shares during the last quarter. GSA Capital Partners LLP acquired a new position in Bionano Genomics during the third quarter valued at approximately $46,000. Finally, Geode Capital Management LLC increased its position in shares of Bionano Genomics by 47.3% during the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after purchasing an additional 283,639 shares during the last quarter. Institutional investors own 11.35% of the company’s stock.
About Bionano Genomics
Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.
Featured Articles
- Five stocks we like better than Bionano Genomics
- Best Stocks Under $10.00
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.